Regeneron Pharmaceuticals
REGN | NASDAQ
$952.40
-$3.07 (-0.32%)
At close: Nov 16, 2026, 4:00 PM ET
$953.36
+$0.96 (+0.10%)
After-hours:
Nov 16, 2026, 7:30 PM ET
Regeneron Pharmaceuticals Statistics
Key statistics explainedMarket Data
$98.51B
$91.91B
0.24
760.01K
105.6M
-1.49%
89.28%
NASDAQ
US75886F1075
Price Performance
20.4%
18.2%
51.3%
23.4%
35.2%
18.7%
48.4%
20.4%
38.0%
8.5%
8.7%
Valuation
21.04
14.09
2.52
0.36
5.83
4.90
2.94
27.46
38.15
21.83
5.44
16.03
14.71
25.62
4.8%
3.6%
2.6%
Financial Health
$7.31B
$2.71B
$9.3B
$44.41B
3.35
2.89
0.08
0.43
0.75
1.70
106.88
7.88
7
Margins & Profitability
85.8%
29.5%
37.0%
28.5%
21.2%
15.3%
6.0%
-28.0%
Returns
10.8%
15.1%
10.9%
13.1%
11.2%
Historical Growth (CAGR)
8.9%
4.5%
13.6%
8.9%
-6.3%
20.7%
-8.0%
-7.8%
15.7%
Analyst Forecasts
Buy
25
22.3%
11.3%
Jan 28, 2027
$25.39
121.9%
$5.85B
50.7%
Fair Value Estimates
$568.37
-40.3%
$226.30
-76.2%
$875.00
-8.1%
Cash Flow
$4.61B
$3.59B
$2.58B
$33.98
$43.63
28.7%
Income Statement
$16.9B
$14.49B
$4.99B
$6.25B
$4.82B
$45.26
$1.1M
$312.62K
15,410
Dividends
$3.70
0.39%
8.2%
10.7%
14.8%
40.1%
Quarterly
Nov 20, 2026
Add to Watchlist
Select watchlists to add or remove REGN